Varicella zoster virus DNA at inoculation sites and in saliva after zostavax immunization

Journal of Infectious Diseases

Volumn 203, Issue 11, 2011, Pages 1542-1545

  Pierson, Duane L ^a   Mehta, Satish K ^b   Gilden, Don ^d   Cohrs, Randall J ^d   Nagel, Maria A ^d   Schmid, D Scott ^e   Tyring, Stephen K ^c  

^a NASA JOHNSON SPACE CENTER   (United States)

^b Enterprise Advisory Services Inc   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VARICELLA ZOSTER VACCINE; VIRUS DNA;

ADULT; AGED; ARTICLE; FEMALE; GENOTYPE; HERPES ZOSTER; HUMAN; INJECTION SITE; MALE; PRIORITY JOURNAL; SALIVA; SKIN; VARICELLA ZOSTER VIRUS; VIRUS IDENTIFICATION; VIRUS SHEDDING;

AGED; AGED, 80 AND OVER; DNA, VIRAL; FEMALE; HERPES ZOSTER VACCINE; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNIZATION; MALE; MIDDLE AGED; SALIVA; SKIN;

EID: 79956192446     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir139     Document Type: Article

References (15)

1. Satyaprakash AK, Stelter AA, Tremaine AM, et al. Viremia in acute herpes zoster. J Infect Dis 2009; 200:26-32.
2. Arvin AM, Moffat JF, Sommer M, et al. Varicella-zoster virus T cell tropism and the pathogenesis of skin infection. Curr Top Microbiol Immunol 2010; 342:189-209.
3. Gilden D, Cohrs RJ, Mahalingam R, Nagel MA. Neurological disease produced by varicella zoster virus reactivation without rash. Curr Top Microbiol Immunol 2010; 342:243-53.
4. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352:2271-84.
5. Mehta SK, Tyring SK, Gilden DH, et al. Varicella-zoster virus in the saliva of patients with herpes zoster. J Infect Dis 2008; 197:654-7. (Pubitemid 351364462)
6. Cohrs RJ, Mehta SK, Schmid DS, Gilden DH, Pierson DL. Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts. J Med Virol 2008; 80:1116-22. (Pubitemid 351657028)
7. Mehta SK, Cohrs RJ, Forghani B, Zerbe G, Gilden DH, Pierson DL. Stress-induced subclinical reactivation of varicella zoster virus in astronauts. J Med Virol 2004; 72:174-9. (Pubitemid 37484760)
8. Gilden DH, Shtram Y, Friedmann A, et al. Extraction of cell-associated varicella-zoster virus DNA with triton X-100-NaCl. J Virol Methods 1982; 4:263-75. (Pubitemid 12073480)
9. Loparev VN, McCaustland K, Holloway BP, Krause PR, Takayama M, Schmid DS. Rapid genotyping of varicella-zoster virus vaccine and wild-type strains with fluorophore-labeled hybridization probes. J Clin Microbiol 2000; 38:4315-9. (Pubitemid 32244512)
10. Loparev VN, Rubtcova E, Seward JF, Levin MJ, Schmid DS. DNA sequence variability in isolates recovered from patients with post vaccination rash or herpes zoster caused by Oka varicella vaccine. J Infect Dis 2007; 195:502-10. (Pubitemid 46214392)
11. Lopez AS, Burnett-Hartman A, Nambiar R, et al. Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004. J Infect Dis 2008; 197:646-53. (Pubitemid 351364461)
12. Chaves SS, Haber P, Walton K, et al. Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005. J Infect Dis 2008; 197(Suppl 2):S170-7.
13. Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: recommendations of the Advisory Committee on immunization Practices (ACIP). MMWR Recomm Rep 2008; 57:1-30.
14. Hammerschlag MR, Gershon AA, Steinberg SP, Clarke L, Gelb LD. Herpes zoster in an adult recipient of live attenuated varicella vaccine. J Infect Dis 1989; 160:535-7.
15. Taha Y, Scott FT, Parker SP, Syndercombe Court D, Quinlivan ML, Breuer J. Reactivation of 2 genetically distinct varicella-zoster viruses in the same individual. Clin Infect Dis 2006; 43:1301-2.